Publicaciones en colaboración con investigadores/as de Hospital Universitario Virgen de las Nieves (28)

2024

  1. Penetrance of Dilated Cardiomyopathy in Genotype-Positive Relatives

    Journal of the American College of Cardiology, Vol. 83, Núm. 17, pp. 1640-1651

2023

  1. Bayesian analysis of the Substrate Ablation vs. Antiarrhythmic Drug Therapy for Symptomatic Ventricular Tachycardia trial

    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, Vol. 25, Núm. 7

  2. Late gadolinium enhancement distribution patterns in non-ischaemic dilated cardiomyopathy: genotype-phenotype correlation

    European heart journal. Cardiovascular Imaging, Vol. 25, Núm. 1, pp. 75-85

  3. Selection of the best of 2022 in familial heart disease and cardiovascular genetics

    REC: CardioClinics, Vol. 58, pp. S68-S73

  4. Spanish cardiac catheterization and coronary intervention registry. 32nd official report of the Interventional Cardiology Association of the Spanish Society of Cardiology (1990-2022)

    Revista Espanola de Cardiologia, Vol. 76, Núm. 12, pp. 1021-1031

2022

  1. Combination of late gadolinium enhancement and genotype improves prediction of prognosis in non-ischaemic dilated cardiomyopathy

    European Journal of Heart Failure, Vol. 24, Núm. 7, pp. 1183-1196

  2. Early clinical outcomes after transaxillary versus transfemoral TAVI. Data from the Spanish TAVI registry

    Revista Espanola de Cardiologia, Vol. 75, Núm. 6, pp. 479-487

  3. Natural History of MYH7-Related Dilated Cardiomyopathy

    Journal of the American College of Cardiology, Vol. 80, Núm. 15, pp. 1447-1461

  4. Selection of the best of 2021 in familial heart disease and cardiovascular genetics

    REC: CardioClinics, Vol. 57, pp. S54-S59

  5. Substrate Ablation vs Antiarrhythmic Drug Therapy for Symptomatic Ventricular Tachycardia

    Journal of the American College of Cardiology, Vol. 79, Núm. 15, pp. 1441-1453

  6. Temporal trend and potential impact of angiotensin receptor neprilysin inhibitors on transcatheter edge-to-edge mitral valve repair

    Revista Espanola de Cardiologia, Vol. 75, Núm. 12, pp. 1001-1010

2021

  1. Association of Genetic Variants With Outcomes in Patients With Nonischemic Dilated Cardiomyopathy

    Journal of the American College of Cardiology, Vol. 78, Núm. 17, pp. 1682-1699

  2. Clinical Risk Prediction in Patients With Left Ventricular Myocardial Noncompaction

    Journal of the American College of Cardiology, Vol. 78, Núm. 7, pp. 643-662

  3. Clinical and echocardiographic outcomes of transcatheter mitral valve repair in atrial functional mitral regurgitation

    International Journal of Cardiology, Vol. 345, pp. 29-35

  4. Impact of Comorbidities and Antiplatelet Regimen on Platelet Reactivity Levels in Patients Undergoing Transcatheter Aortic Valve Implantation

    Journal of cardiovascular pharmacology, Vol. 78, Núm. 3, pp. 463-473

  5. Persistent pulmonary hypertension in corrected valvular heart disease: Hemodynamic insights and long-term survival

    Journal of the American Heart Association, Vol. 10, Núm. 2, pp. 1-21

  6. Risk predictors in a Spanish cohort with cardiac laminopathies. The REDLAMINA registry

    Revista Espanola de Cardiologia, Vol. 74, Núm. 3, pp. 216-224

2020

  1. Impact of COVID-19 on ST-segment elevation myocardial infarction care. The Spanish experience

    Revista Espanola de Cardiologia, Vol. 73, Núm. 12, pp. 994-1002

  2. Transcatheter mitral repair for functional mitral regurgitation according to left ventricular function: A real-life propensity-score matched study

    Journal of Clinical Medicine, Vol. 9, Núm. 6, pp. 1-14

2019

  1. Assessment of Platelet REACtivity After Transcatheter Aortic Valve Replacement: The REAC-TAVI Trial

    JACC: Cardiovascular Interventions, Vol. 12, Núm. 1, pp. 22-32